Improving plant regeneration

By induced callus formation in plant cells such as beets, the problem of difficulty in forming callus and regeneration in plants such as beets is solved, and the transformation and breeding efficiency is significantly improved.

CN118909909APending Publication Date: 2024-11-08KWS SAAT SE & CO KGAA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410981755.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2019-03-12
Filing Date
2020-03-12
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Plants such as beets are difficult to form callus and regenerate, resulting in genotype mutation and inefficiency problems during transformation and breeding.

Method used

Plant cells are induced under specific conditions using hyperphyllin or derivatives thereof to promote the formation and regeneration of callus tissue by the presence of hyperphyllin or derivatives thereof in culture medium or directly into cells.

Benefits of technology

It significantly improves callus induction and regeneration efficiency of stubborn genotype plants such as beets, produces robust callus suitable for transformation and gene editing, and improves transformation efficiency and regeneration rate.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909909A_ABST
    Figure CN118909909A_ABST
Patent Text Reader

Abstract

The present invention relates to the field of plant breeding, in particular to plant regeneration from cells and other tissues. More specifically, the present invention provides methods and means for improving the formation and regeneration of plant calluses and seedlings using hyperphyllin or a derivative thereof.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The present invention relates to the field of plant breeding, and in particular to plant regeneration from cells and other tissues. More specifically, the present invention provides methods and means for improving plant callus and shoot formation and regeneration using hyperphyllin or its derivatives.

[0002] Plant regeneration involves the in vitro cultivation of cells, tissues and organs under defined physical and chemical conditions. Regeneration has long been known to occur in plants. In plants, differentiated cells are able to regenerate a complete array of tissues under appropriate culture conditions. Regeneration can involve direct or indirect organogenesis. In direct regeneration, in vitro organs are induced directly from explant tissues; in indirect regeneration, new organs are usually formed from intermediate tissues (callus). Plant callus is an undifferentiated structure that can produce new tissues. Plant leaves, shoots, roots and embryos can be produced in a variety of ways from growing callus.

[0003] In general, three stages can be identified throughout the plant regeneration process. First, somatic cells of the explant tissue can respond to hormone signals to acquire meristem cell-like characteristics, a process known as "dedifferentiation". Second, under the influence of hormone balance, callus cells with organogenesis capacity are reprogrammed and determined for specific organ formation. The third regeneration stage (morphogenesis) is independent of exogenously supplied hormones. It can be seen that in in vitro regeneration, exogenous hormone treatment is a key factor in triggering early developmental events.

[0004] However, obtaining dedifferentiated cells (callus) that can regenerate into a complete plant is not always feasible for many plant species. Dedifferentiation and plant regeneration are known to be difficult to occur in sugar beet. These difficulties are major obstacles to obtaining transgenic sugar beet, for example, by Agrobacterium-mediated transformation procedures. For decades, breeders and researchers are working on developing more effective transformation and regeneration protocols for plants that are difficult to form callus. Typically, such plants exhibit genotypic variation, resulting in large differences in callus and shoot formation rates between different lines (Ivic-Haymes & Smigocki (2005), "Identification of highly regenerative plants within sugar beet (Beta vulgaris L.) breeding lines for molecular breeding." In Vitro Cellular and Developmental Biology-Plant, 41(4), 483-488; Mishutkina & Gaponenko (2006), "Sugar beet (Beta vulgaris L.) morphogenesis in vitro: effects of phytohormone type and concentration in the culture medium, type of explants, and plant genotype on shoot regeneration frequency." Russian Journal of Genetics, 42(2), 150-157; Tomita et al. (2013), "Evaluation of the potential for somatic embryogenesis in sugar beet (Beta vulgaris L.) breeding lines and improvement of regeneration efficiency." Plant Biotechnology, 30(5), 479-487.). Often, regeneration of certain genotypes is simply not feasible.Kishchenko et al. (2005) (Production of transgenetic sugarbeet (Beta vulgaris L.) plants resistant to phosphinothricin." Cell biology international, 29 (1), 15-19.) and Kagami et al. (2005) ("Sugar beet (Beta vulgaris L.)." Agrobacterium Protocols: Volume 1, 335-347.) disclosed well-known sugar beet transformation protocols, however, these protocols show strong genotype dependence.

[0005] Chaudhury et al. (1993. "amp1-a mutant with high cytokinin levels and altered embryonic pattern, faster vegetative growth, constitutive photomorphogenesis and precocious flowering." The Plant Journal, 4(6), 907-916.) first described the amp1 (altered meristem program 1) mutant of Arabidopsis thaliana, which has altered phenotypes in three different aspects of plant development; spatial pattern, photomorphogenic growth and the onset of flowering. Amp1 (At3G54720) belongs to the M28B peptidase family of Zn 2+AMP1 is a metalloproteinase-dependent protein (Helliwell et al., 2001. "The Arabidopsis AMP1 gene encodes a putative glutamate carboxypeptidase." The Plant Cell, 13 (9), 2115-2125.). AMP1 antagonistically regulates the development of embryos and meristems in Arabidopsis and is involved in the development of shoot apical meristems. The amp1 mutant exhibits enlarged shoot apical meristems (Vidaurre et al., 2007. "AMP1 and MP antagonistically regulate embryo and meristem development in Arabidopsis." Development, 134 (14), 2561-2567.). Mordhorst et al. (1998. "Somatic embryogenesis in Arabidopsis thaliana is facilitated by mutations in genes repressing meristematic cell divisions." Genetics, 149 (2), 549-563.) showed that amp1 mutants promoted somatic embryogenesis in Arabidopsis. In 2016, Poretska et al. ("The small molecule hyperphyllin enhances leaf formation rate and mimics shoot meristemintegritydefects associated with AMP1 deficiency." Plant physiology, pp-01633.) demonstrated that the small molecule hyperphyllin (HP) and its three derivatives (A1, A2 and A3) enhanced leaf formation rate and mimicked the amp1 mutant phenotype. HP treatment of Arabidopsis resulted in changes in the expression of genes related to biological interactions and stress responses. Although there seems to be an interaction between AMP1 and HP treatment, the functional relationship is not yet fully understood.

[0006] Surprisingly, the inventors found that by applying the chemical HP or its derivatives to beet leaf tissue explants, callus induction was significantly promoted even from stubborn genotypes. The resulting callus can be regenerated into normal seedlings, and the resulting plants exhibit a normal phenotype. The induced callus is robust enough to be suitable for transformation and gene editing. The prior art describes the effect of the chemical HP mimicking the amp1 mutant in Arabidopsis, with only enlarged seedling apical meristems. Although the amp1 mutant exhibits enhanced regeneration ability, such a favorable enhancement effect in callus formation induced by the chemical HP has never been shown in Arabidopsis or any other crop.

[0007] Therefore, a first aspect of the present invention is the use of hyperphyllin or a derivative thereof in a method for inducing plant callus formation.

[0008] The present invention provides a method for inducing callus formation from plant cells, comprising incubating plant cells ( Figure 1 ).

[0009] Hyperphyllin is N-[4-amino-2-chlorophenyl]-2,4-dichlorobenzamide, as shown below.

[0010]

[0011] In addition to hyperphyllin, derivatives thereof may also be used in the process of the invention. Preferred derivatives are benzanilides substituted at one or more positions of one or both of the phenyl rings 1 and 2, in particular at the ortho and / or para positions relative to the amide function. The substituents may be selected in particular from halogens, such as Cl or F; amino groups, such as NH2; substituted amino groups -NHR and -NR2, wherein R may be, for example, C1-4 alkyl groups such as methyl or ethyl and alkyl groups, such as C1-4 alkyl groups such as methyl or ethyl and alkyl groups. Most preferably, the derivatives are selected from the compounds of formulae A1, A2 and A3 shown below.

[0012]

[0013] The presence of hyperphyllin or a derivative thereof in the incubation step can be achieved, for example, by incubating the plant cells in a medium containing hyperphyllin or a derivative thereof, or by introducing the hyperphyllin or a derivative thereof directly into the plant cells, for example via bombardment, electroporation or microinjection. Preferably, callus formation is induced in a medium containing hyperphyllin or a derivative thereof.

[0014] In principle, it is sufficient to use only one plant cell to induce callus formation. Therefore, if the plural "plant cells" are used below, this term is not to be understood as a minimum number of plant cells that may be required.

[0015] Plant cells that are suitable for inducing callus include germline plant cells and somatic plant cells. How to provide these plant cells is unimportant for the method according to the present invention. Plant cells can be used in a separated form or used as the part of plant tissue. For example, germline or somatic plant cells can be provided from the explant separated from the plant. Cells are separated from the explant or directly the explant is used to induce callus. Which part of the plant meets the condition of obtaining the explant depends on specific plant species. Usually, suitable plant cells can be obtained from the hypocotyl, seedling, leaf, bud, flower, petiole and root of the plant.

[0016] Surprisingly, it was found that hyperphyllin and its derivatives are suitable for inducing callus formation even in recalcitrant plant species or plant genotypes.

[0017] Any culture medium known in the art can be used for the incubation step, particularly a culture medium that is generally used to induce callus formation. Depending on the plant in question, the composition of the culture medium can vary. In principle, several types of basal salt mixtures can be added to the culture medium, but preferably the culture medium includes a modified Murashige and Skoog (MS) culture medium, a White culture medium or a woody plant culture medium, most preferably an MS culture medium. Previous studies have shown that plant growth hormones and cytokinins are conducive to the induction of callus when present in MS culture medium alone or in combination with each other in suitable amounts and concentrations. According to the present invention, these components can also be preferentially added to the culture medium. Exemplary plant growth hormones include naphthaleneacetic acid (NAA), indole-3-acetic acid (IAA) and indole-3-butyric acid (IBA). Exemplary cytokinins include 6-benzylaminopurine (BAP) and 6-furanaminopurine (kinesin).

[0018] The concentration range of hyperphyllin or its derivatives in the culture medium is about 5 μM to about 200 μM, preferably about 10 μM to about 100 μM, more preferably about 20 μM to about 80 μM, and most preferably about 30 μM to about 50 μM. In order to achieve the desired enhancement of callus formation, the concentration range of hyperphyllin or its derivatives in the culture medium is preferably about 20 μM to about 80 μM, more preferably about 30 μM to about 50 μM. In addition, more additives for inducing callus known in the art can be added. For example, the culture medium for inducing callus formation according to the present invention can include MS salts, sucrose, BAP and hyperphyllin.

[0019] According to another aspect of the present invention, it has been found that the callus obtained according to the above method in the presence of hyperphyllin or a derivative thereof is surprisingly well suited to generate shoots and eventually whole plants, even for recalcitrant plant species or plant genotypes. Thus, the indirect regeneration of recalcitrant plant species or plant genotypes can be improved using the method of the present invention.

[0020] Therefore, the present invention provides a method for producing plant shoots, comprising

[0021] (i) inducing callus formation according to the above method to produce callus, and

[0022] (ii) culturing callus under conditions suitable for inducing shoot formation.

[0023] Any known culture medium can be used to carry out the culture step to grow callus and induce shoot formation.Depending on the plant in question, these conditions can change.In principle, several types of basal salt mixtures can be used to cultivate callus, but most preferably, culture medium comprises improved Murashige and Skoog culture medium, White culture medium or woody plant culture medium.For the convenience of seedling induction, one or more additives can be used in the culture medium.The culture medium can supplement plant growth regulators, such as plant growth hormones and cytokinins. Vitamins that strengthen growth can be provided, such as Gamborg B5 vitamins.The enrichment of nitrogen, phosphorus and potassium has also been shown to be helpful.For example, the culture medium that is used to cultivate callus to produce seedling formation can comprise MS salts, sucrose, BAP and kanamycin.

[0024] According to another aspect of the invention, the beneficial effect of hyperphyllin or its derivatives, especially derivatives of general formula A1, A2 or A3, on callus formation can be utilized in methods for producing transgenic plants and methods for producing genetically modified plants. Studies have found that in recalcitrant plant species or plant genotypes, the use of hyperphyllin or its derivatives, especially derivatives of general formula A1, A2 or A3, can improve the transformation efficiency. When hyperphyllin or its derivatives, especially derivatives of general formula A1, A2 or A3, are present in the callus formation step, the regeneration of plants from modified plant cells that have been transformed or gene-edited and may have a modified genome is significantly improved.

[0025] Therefore, the present invention provides a method for producing a transgenic plant, comprising the following steps:

[0026] (a) inducing callus formation according to the above method to produce callus

[0027] (b) introducing at least one nucleotide sequence of interest or at least one polypeptide of interest into the plant cells to be used in step (a) and / or into the cells of the callus obtained in step (a),

[0028] (c) cultivating the callus obtained from steps (a) and (b) according to the above method to produce plantlets, and

[0029] (d) Regeneration of transgenic plants.

[0030] Step (a) of inducing callus formation comprises incubating the plant cells in the presence of hyperphyllin or a derivative thereof, in particular a derivative of formula A1, A2 or A3. Suitable plant cells and conditions are as defined above.

[0031] In step (b), the cell is transformed by introducing a nucleic acid molecule into the cell to cause stable or transient presence of the nucleic acid sequence (preferably stable or transient expression of the nucleic acid sequence) or by introducing a polypeptide into the cell in a manner that causes transient presence. For example, the stable presence of a DNA sequence means that the DNA sequence is stably integrated into the genome of the cell. Stable expression refers to, for example, the expression of a DNA sequence that is stably integrated into the genome of the cell. Transformation of both monocotyledonous and dicotyledonous plant cells is now routine, and the choice of the most appropriate transformation technique will be determined by the experimenter. The choice of method varies with the type of plant to be transformed; those skilled in the art will recognize the applicability of a particular method for a given plant type. Suitable methods may include, but are not limited to: electroporation of plant protoplasts; liposome-mediated transformation; polyethylene glycol (PEG)-mediated transformation; transformation using viruses; microinjection of plant cells; microprojectile bombardment of plant cells; vacuum infiltration; and Agrobacterium-mediated transformation.

[0032] According to one embodiment of the present invention, at least one nucleotide sequence of interest or at least one polypeptide of interest is introduced into the plant cell of step (a) to be used for inducing callus formation. It should be understood that in this case step (b) is performed before step (a). According to another embodiment of the present invention, at least one nucleotide sequence of interest or at least one polypeptide of interest is introduced into the cell of the callus obtained in step (a). It should be understood that in this case step (b) is performed after step (a). In addition, the nucleotide sequence of interest or the polypeptide of interest can be introduced simultaneously into the cell to be used for callus formation and the callus cell produced in step (a). According to this embodiment, the method comprises the following steps:

[0033] (i) introducing at least one nucleotide sequence of interest or at least one polypeptide of interest into a plant cell,

[0034] (ii) inducing the cells obtained in step (i) to form callus, and

[0035] (iii) introducing at least one nucleotide sequence of interest or at least one polypeptide of interest into cells of the callus obtained in step (ii).

[0036] Using any suitable method known in the art, the step of introducing at least one nucleotide sequence of interest or at least one polypeptide of interest can be carried out. Many methods as described above can be used for transferring nucleic acid of interest or polypeptide into plant cells. For example, as Lindsey & Gallois, 1990, Journal of Experimental Botany and Kischenko et al., 2005, Cell Biology International, Ishida et al., 2007, ("Agrobacterium-mediated transformation of maize." Nature protocols, 2 (7), 1614-1621, for corn), or as described in PureWheat Technology from Japan Tobacco company (for wheat), the method of introducing DNA molecules mediated by exemplary vectors is Agrobacterium-mediated transformation. Other technologies that are also suitable for introducing RNA molecules or polypeptides include particle bombardment and electroporation.

[0037] The nucleotide sequence of interest according to the present invention can be a DNA or RNA sequence, such as mRNA, siRNA, miRNA, tRNA, etc. More particularly, the nucleotide sequence of interest can encode a polypeptide that confers at least one phenotypic trait. Preferably, the phenotypic trait conferred by the polypeptide can be selected from resistance / tolerance to biotic stress, including resistance / tolerance to pathogens, wherein the pathogens can be viral, bacterial, fungal or animal pathogens; resistance / tolerance to abiotic stress, including cold resistance / tolerance, drought resistance / tolerance, osmotic resistance / tolerance, heat stress resistance / tolerance, cold or frost stress resistance / tolerance, oxidative stress resistance / tolerance, heavy metal stress resistance / tolerance, salt stress or waterlogging resistance / tolerance, lodging resistance / tolerance, seed shattering resistance / tolerance, or resistance / tolerance to one or more herbicides (such as glyphosate, glufosinate, 2,4-D, dicamba, ALS inhibitors, etc.). At least one phenotypic trait of interest may also be selected from the modification of another agronomic trait of interest, including increased yield, altered flowering time, altered seed color, altered endosperm composition, modified nutrient content, or metabolic engineering of pathways of interest. In addition, the nucleotide sequence of interest may encode a component of a gene editing mechanism or may be a component of a gene editing mechanism, such as a gRNA, crRNA, tracrRNA, sgRNA, nuclease, disarmed nuclease, nickase, disarmed nickase, base editor, TALE recognition domain or zinc finger recognition domain or a fusion protein comprising such a recognition domain, etc.

[0038] As used herein, nucleic acid (molecule) or nucleotide (sequence) or polynucleotide refers to DNA and RNA. DNA also includes cDNA and genomic DNA. Nucleic acid molecules can be single-stranded or double-stranded, and can be chemically synthesized or produced by in vitro or even in vivo biological expression.

[0039] Obviously, whenever the nucleotide sequence of an RNA molecule is defined by reference to the nucleotide sequence of a corresponding DNA molecule, thymine (T) in the nucleotide sequence should be replaced by uracil (U). The reference to RNA or DNA molecules is clear from the context of the present application.

[0040] The polypeptide of interest according to the present invention can be a transcription factor, a protein component of a gene editing mechanism (such as a nuclease, a nickase, a base editor, a TAL effector or a recognition domain of a zinc finger effector), or can be a polypeptide that confers a phenotypic trait, which can be selected from resistance / tolerance to one or more herbicides (such as glyphosate, glufosinate, 2,4-D, dicamba, ALS inhibitors, color markers, fluorescent markers, etc.); resistance / tolerance to biotic stresses, including resistance / tolerance to pathogens, wherein the pathogens can be viruses, bacteria, fungi or animal pathogens; resistance / tolerance to abiotic stresses, including cold resistance / tolerance, drought resistance / tolerance, osmotic resistance / tolerance, heat stress resistance / tolerance, cold or frost stress resistance / tolerance, oxidative stress resistance / tolerance, heavy metal stress resistance / tolerance, salt stress or waterlogging resistance / tolerance, lodging resistance / tolerance, grain shattering resistance / tolerance, etc. The polypeptide of interest can be chemically synthesized or produced by biological expression in vitro or even in vivo.

[0041] In the above-mentioned method for producing transgenic plants, steps (c) and (d) comprise the modified callus of transformed plant cells regenerated into complete (fertile) plants. Thus, in step (c), the callus is cultured under conditions suitable for inducing shoot formation and finally regenerated into complete plants in step (d).

[0042] Regeneration techniques rely on the manipulation of certain plant hormones in tissue culture growth medium, occasionally rely on antimicrobial and / or herbicide markers that can be introduced together with the desired nucleotide sequence of interest. Evans et al., Protoplasts Isolation and Culture, Handbook of Plant Cell Culture, pp.124-176, MacMillilan Publishing Company, New York, 1983 and Binding, Regeneration of Plants, Plant Protoplasts, pp.21-73, CRC Press, Boca Raton, 1985 describe plant regeneration from cultivated protoplasts. Regeneration can also be obtained from plant callus, explants, protoplasts, immature or mature embryos, embryo-like tissues, meristems, organs or parts thereof. Such regeneration techniques are usually described in Klee (1987) Ann.Rev.of Plant Phys.38:467-486. In order to obtain complete plants from transgenic tissues such as immature embryos, they can be grown under controlled environmental conditions in a series of culture media containing nutrients and hormones, and the process is called tissue culture. Once whole plants are established and producing seeds, evaluation of the progeny begins.

[0043] In addition, the present invention also provides a method for producing a genetically modified plant, comprising the following steps:

[0044] (a) inducing callus formation from at least one plant cell according to the above method to produce callus,

[0045] (b) modifying the genome of the plant cells to be used in step (a) and / or the genome of the cells of the callus tissue obtained in step (a) by introducing into the cells a single-strand DNA break (SSB)-inducing enzyme or a double-strand DNA break (DSB)-inducing enzyme that preferably recognizes a predetermined site in the genome of the cell, and optionally a repair nucleic acid molecule, and / or a base editor fused to an SSB-inducing enzyme that preferably recognizes a predetermined site in the genome of the cell or a catalytically impaired SSB or DSB-inducing enzyme,

[0046] wherein the genomic modification is selected from

[0047] i. substitution of at least one nucleotide;

[0048] ii. a deletion of at least one nucleotide;

[0049] iii. insertion of at least one nucleotide; or

[0050] iv. Any combination of i.-iii.,

[0051] (c) cultivating the callus obtained from steps (a) and (b) according to the above method to produce plantlets, and

[0052] (d) Regenerating the genetically modified plant.

[0053] The step (a) of inducing callus formation is carried out by the above method. Thus, callus formation is induced in the presence of hyperphyllin or its derivatives; and hyperphyllin or its derivatives can be added to the culture medium or directly added to the plant cells.

[0054] In step (b), modification of the cell genome is accomplished by: a single-strand DNA break (SSB)-inducing enzyme or a double-strand DNA break (DSB)-inducing enzyme that preferably recognizes a predetermined site in the cell genome and / or a base editor fused to an SSB-inducing enzyme that preferably recognizes a predetermined site in the cell genome or a catalytically impaired SSB or DSB-inducing enzyme.

[0055] The step of modifying the genome can be performed before and / or after inducing callus formation. Therefore, according to a first aspect of the present invention, the genome of the plant cell is modified as described in step (b), and the modified plant cell obtained is then used in the subsequent step (a) of inducing callus formation. According to another aspect of the present invention, the step (a) of inducing callus formation is first performed, and then in step (b), at least one cell of the resulting callus is modified by a single-strand DNA break (SSB) inducing enzyme or a double-strand DNA break inducing enzyme and / or by a base editor fused to a catalytically impaired SSB or DSB inducing enzyme or fused to an SSB inducing enzyme. In addition, it is possible to modify the genome of the plant cell to be used for the step of callus formation and the genome of the callus cell obtained by the step of inducing callus formation. According to this aspect of the present invention, the method comprises the following steps:

[0056] (i) modifying the genome of a plant cell,

[0057] (ii) inducing callus formation from the cells obtained in step (i), and

[0058] (iii) modifying the genome of the callus cells obtained in step (ii).

[0059] As used herein, a "double-strand DNA break-inducing enzyme" or "DSB-inducing enzyme" or "DSBI enzyme" is an enzyme that can induce double-stranded DNA breaks at a specific nucleotide sequence (referred to as a "recognition site" or "predetermined site" or "predetermined target site"). Thus, a "single-strand DNA break-inducing enzyme", "single-strand break-inducing enzyme" or "SSBI enzyme" is an enzyme that can induce single-stranded DNA or RNA breaks at a specific nucleotide sequence (referred to as a "recognition site" or "predetermined (target) site" or "predefined (target) site").

[0060] In recent years, many suitable nucleases have been developed, in particular custom endonucleases (including double-strand DNA break (DSB) inducing enzymes), which can be selected from, for example, large-range nucleases, TAL effector nucleases, zinc finger nucleases, CRISPR nucleases (e.g., including Cas9, Cpf1, Csm1, CasX or CasY nucleases as part of the clustered regularly interspaced short palindromic repeat (CRISPR) system). Therefore, in a preferred aspect of the present invention, the genome modification is mediated by a DSB or SSB inducing enzyme or a variant thereof, which is selected from CRISPR / Cas endonucleases, preferably CRISPR / Cas9 endonucleases; CRISPR / Cpf1 endonucleases; CRISPR / MAD7 endonucleases or CRISPR / Csm1 endonucleases; zinc finger nucleases (ZFNs); homing endonucleases; large-range nucleases and TAL effector nucleases.

[0061] Rare cutting endonucleases are DSBI enzymes, which have a recognition site preferably of about 14 to 70 consecutive nucleotides, so the cutting frequency is very low, even in larger genomes (such as most plant genomes). Homing endonucleases, also known as meganucleases, constitute this type of rare cutting endonuclease family. They can be encoded by introns, independent genes or insertion sequences, and present surprising structural and functional properties to distinguish them from more classical restriction endonucleases, usually distinguished from bacterial restriction modification type II systems. Their recognition sites have a general asymmetry, which contrasts with the characteristic binary symmetry of most restriction enzyme recognition sites. Several homing endonucleases encoded by introns or inteins have been shown to promote their respective genetic elements to home to alleles without introns or without intron sites. By performing site-specific double-strand breaks in intronless or intronless alleles, these nucleases cause recombinant ends, which participate in the gene conversion process of replicating coding sequences, and result in the insertion of introns or insertion sequences at the DNA level. A list of other rare-cutting meganucleases and their respective recognition sites is provided in Table I (pp. 17-20) of WO 03 / 004659 (incorporated herein by reference).

[0062] In addition, the method can be used to design customized rare-cutting endonucleases that recognize essentially any selected target nucleotide sequence. In brief, chimeric restriction endonucleases can be prepared using a hybrid between a zinc finger domain (designed to recognize a specific nucleotide sequence) and a non-specific DNA cleavage domain from a natural restriction endonuclease (such as FokI). Such methods have been described in WO 03 / 080809, WO 94 / 18313 or WO 95 / 09233 and Isalan et al., 2001, Nature Biotechnology 19, 656-660; Liu et al. 1997, Proc. Natl. Acad. Sci. USA 94, 5525-5530).

[0063] Another example of a custom-designed endonuclease includes the so-called TALE nucleases (TALENs), which are based on the transcription activator-like effector (TALE) of the bacterial genus Xanthomonas fused to the catalytic domain of a nuclease (e.g., FokI or its variants). The DNA binding specificity of these TALEs is defined by the repeated variable diresidues (RVDs) of 34 / 35 amino acid repeat units arranged in tandem, such that one RVD specifically recognizes one nucleotide in the target DNA. The repeat units can be assembled to recognize essentially any target sequence and fused to the catalytic domain of a nuclease to create a sequence-specific endonuclease (see, e.g., Boch et al., 2009, Science 326: p1509-1512; Moscou and Bogdanove, 2009, Science 326: p1501; and WO 2010 / 079430, WO 2011 / 072246, WO 2011 / 154393, WO 2011 / 146121, WO 2012 / 001527, WO 2012 / 093833, WO 2012 / 104729, WO 2012 / 138927, WO 2012 / 138939). WO2012 / 138927 further describes monomeric (compact) TALENs and TALENs with multiple catalytic domains and combinations thereof.

[0064] Recently, a new customizable endonuclease system, the so-called CRISPR / Cas system, has been described. The CRISPR system in its natural environment describes a molecular complex comprising at least one small and separate non-coding RNA combined with Cas nuclease or another CRISPR nuclease such as Cpf1 nuclease (Zetsche et al. "Cpf1 Is a Single RNA-Guides Endonuclease of a Class 2 CRISPR-Cas System", Cell, 163, pp.1-13, October 2015), MAD7 nuclease or Csm1 nuclease. At present, CRISPR systems are divided into 2 categories, including 5 types of CRISPR systems, such as type II systems using Cas9 as effectors, and type V systems using Cpf1 as effectors (Makarova et al., Nature Rev. Microbiol., 2015). In artificial CRISPR systems, synthetic non-coding RNAs and CRISPR nucleases and / or modified CRISPR nucleases that are optionally modified to function as nickases or lack any nuclease function can be combined with at least one synthetic or artificial guide RNA or gRNA that combines crRNA and / or tracrRNA functions (Makarova et al., 2015, supra). CRISPR / Cas-mediated immune responses in natural systems require CRISPR-RNA (crRNA), wherein the maturation of this guide RNA that controls the specific activation of CRISPR nucleases is significantly different between the various CRISPR systems that have been characterized so far. First, the invading DNA (also called the spacer) is integrated between two adjacent repeat regions at the proximal end of the CRISPR locus. The type II CRISPR system encodes the Cas9 nuclease as a key enzyme in the interference step, and the system also contains crRNA and trans-activating RNA (tracrRNA) as guide motifs. These hybridize and form a double-stranded (ds) RNA region, which is recognized by RNAseIII and can be sheared to form a mature crRNA. These then in turn bind to the Cas molecule to specifically guide the nuclease to the target nucleic acid region. Recombinant gRNA molecules can include both variable DNA recognition regions and Cas interaction regions and can therefore be designed independently of the specific target nucleic acid and desired Cas nuclease specificity.

[0065] As a further safety mechanism, PAM (protospacer adjacent motif) must be present in the target nucleic acid region; these are DNA sequences that directly follow the DNA recognition by the Cas9 / RNA complex. The PAM sequence of Streptococcus pyogenes Cas9 has been described as NGG or NAG (standard IUPAC nucleotide code, Jinek et al, "A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity", Science 2012, 337: 816-821). The PAM sequence of Staphylococcus aureus Cas9 is "NNGRRT" or ""NNGRR (N)". Other variant CRISPR / Cas9 systems are known. Thus, Neisseria meningitidis Cas9 cuts at the PAM sequence NNNNGATT. Streptococcus thermophilus Cas9 cuts at the PAM sequence NNAGAAW. Recently, another PAM motif NNNNRYAC of the Campylobacter CRISPR system has been described (WO2016 / 021973 A1). For the Cpf1 nuclease, it has been described that the Cpf1-crRNA complex without tracrRNA effectively recognizes and cuts target DNA treated with a short T-rich PAM, in contrast to the common G-rich PAM recognized by the Cas9 system (Zetsche et al., supra). Furthermore, by using modified CRISPR polypeptides, specific single-strand breaks can be obtained. The combined use of Cas nickases with various recombinant gRNAs can also induce highly specific DNA double-strand breaks by means of double DNA cutting. In addition, by using two gRNAs, the specificity of DNA binding can be optimized, thereby optimizing DNA cutting. Other CRISPR effectors, such as the CasX and CasY effectors originally described for bacteria, are also available and represent other effectors that can be used for genome engineering purposes (Burstein et al., "New CRISPR-Cas systems from uncultivated microbes", Nature, 2017, 542, 237-241).

[0066] The cleavage site of the DSBI / SSBI enzyme refers to the exact position of the induced break on the DNA or RNA. The cleavage site may or may not contain (overlap on) the recognition site of the DSBI / SSBI enzyme, so it can be said that the cleavage site of the DSBI / SSBI enzyme is located at or near its recognition site. The recognition site of the DSBI / SSBI enzyme, sometimes also referred to as the binding site, is a nucleotide sequence that the DSBI / SSBI enzyme (specifically) recognizes and determines its binding specificity. For example, a TALEN or ZNF monomer has a recognition site determined by its RVD repeat sequence or ZF repeat sequence, respectively, and its cleavage site is determined by its nuclease domain (e.g., FokI) and is generally located outside the recognition site. In the case of a dimeric TALEN or ZFN, the cleavage site is located between the two recognition / binding sites of each monomer, and this region of inserted DNA or RNA where cleavage occurs is referred to as a spacer.

[0067] One skilled in the art can either select and recognize a DSBI / SSBI enzyme (whose specific recognition site and cleavage site at or near a preselected / predetermined site that induces DSB or SSB), or can engineer such a DSBI / SSBI enzyme. Alternatively, a DSBI / SSBI enzyme recognition site can be introduced into the target genome using any conventional transformation method or by hybridization with an organism having a DSBI / SSBI enzyme recognition site in its genome, and then any desired nucleic acid can be introduced at or near the cleavage site of the DSBI / SSBI enzyme.

[0068] In some embodiments, one or more double-strand breaks or one or more single-strand breaks are induced, followed by non-homologous end joining (NHEJ) and / or homology-directed break repair by a homologous recombination mechanism (HDR). NHEJ and HDR are two major and different pathways for repairing breaks. Homologous recombination requires the presence of a homologous sequence as a template (such as a repair nucleic acid molecule or "donor") to guide the cell repair process, and the results of the repair are error-free and predictable. In the absence of a template (or repair nucleic acid molecule or "donor") sequence for homologous recombination, the cell typically attempts to repair the break by a non-homologous end joining (NHEJ) process.

[0069] In a particularly preferred aspect of this embodiment, a repair nucleic acid molecule is additionally introduced into the plant cell.

[0070] As used herein, "repair nucleic acid molecule" is a single-stranded or double-stranded DNA molecule or RNA molecule, which is used as a template for genomic DNA modification near or at the cleavage site. As used herein, "used as a template for genomic DNA modification" refers to homologous recombination between the corresponding homologous regions in the target genome flanking the preselected site, optionally with a combination of non-homologous end connection (NHEJ) at one of the two ends of the repair nucleic acid molecule (for example, if there is only one flanking region), and the repair nucleic acid molecule is replicated or integrated at the preselected site. Integration by homologous recombination will allow the repair nucleic acid molecule to be accurately connected to the target genome until the nucleotide level, and NHEJ can cause small insertions / deletions at the junction of the repair nucleic acid molecule and the genomic DNA.

[0071] In various embodiments of the aspects described herein, the genome is modified, wherein the genome is altered by at least one nucleotide. The genome can be modified by insertion of a transgene (preferably comprising an expression cassette for a transgene of interest), substitution of at least one nucleotide, and / or deletion of at least one nucleotide, and / or insertion of at least one nucleotide, as long as it results in a total change of at least one nucleotide compared to the nucleotide sequence of the preselected genomic target site before modification, thereby allowing identification of the modification, for example by techniques such as sequencing or PCR analysis, which will be well known to those skilled in the art.

[0072] As used herein, "base editor" refers to a protein or a fragment thereof that has the ability to mediate targeted base modification, i.e., the conversion of a target base that causes a target point mutation. Preferably, at least one base editor in the context of the present invention is temporarily or permanently fused to at least one DSBI enzyme, or optionally fused to a component of at least one DSBI. The fusion can be covalent and / or non-covalent. Multiple publications have shown that targeted base conversions are mainly from cytosine (C) to thymine (T) using CRISPR / Cas9 nickases or non-functional nucleases connected to a cytidine deaminase domain (mRNA editing catalytic polypeptide (APOBEC1) of apolipoprotein B, such as APOBEC derived from rats). Cytidine deaminase catalyzes the deamination of cytosine (C) and produces uracil (U), which has the base pairing properties of thymine (T). Most known cytidine deaminases work on RNA, and a few examples of known DNA acceptance require single-stranded (ss) DNA. Studies on dCas9 targeting DNA complexes have shown that at least 9 nucleotides (nt) of the displaced DNA strand are unpaired when the Cas9 guide RNA-DNA "R-loop" complex is formed (Jore et al., Nat. Struct. Mol. Biol., 18, 529-536 (2011)). In fact, in the structure of the Cas9 R-loop complex, the first 11nt of the prototype spacer on the replaced DNA strand are disordered, indicating that their movement is not highly restricted. It has also been speculated that the mutations induced by the Cas9 nickase at the cytosine of the non-template strand can come from the accessibility of the cellular cytosine deaminase to it. It can be inferred that this telescopic subset of ssDNA in the R-loop can serve as an effective substrate for the dCas9 tethered cytidine deaminase to directly and programmably convert C in DNA to U (Komor et al., supra). Recently, Goudelli et al. ((2017). Programmable base editing of A·T toG·C in genomic DNA without DNA cleavage. Nature, 551(7681), 464.) described adenine base editing (ABE) that mediates the conversion of A·T to G·C in genomic DNA.

[0073] As used herein, "modification of a genome" means that the genome is altered by at least one nucleotide. This genome modification may occur by substitution of at least one nucleotide, and / or deletion of at least one nucleotide, and / or insertion of at least one nucleotide, as long as it results in a total change of at least one nucleotide compared to the nucleotide sequence of the preselected genomic target site before modification, thereby allowing for identification of the modification, for example, by techniques such as sequencing or PCR analysis, which will be well known to those skilled in the art.

[0074] As used herein, "recognition site" or "preselected (target) site" or "predetermined (target) site" refers to a specific nucleotide sequence in a genome (e.g., a nuclear genome) where one or more nucleotides are to be inserted, replaced, and / or deleted. For example, this can be an endogenous locus or a specific nucleotide sequence in or connected to a previously introduced exogenous DNA or transgene. The preselected site can be a specific nucleotide position where (after) one or more nucleotides are expected to be inserted. The preselected site can also include a sequence of one or more nucleotides that will be exchanged (replaced) or deleted.

[0075] As used in the context of this application, the term "about" refers to + / -10% of the stated value, preferably + / -5% of the stated value. For example, about 100 nucleotides (nt) should be understood as a value between 90 and 110 nt, preferably between 95 and 105.

[0076] As used herein, "flanking region" refers to the region of a repair nucleic acid molecule having a nucleotide sequence homologous to the nucleotide sequence of the DNA region flanking (i.e., upstream or downstream) a preselected site. Obviously, the length of the flanking region and the sequence identity percentage should be selected so as to enable homologous recombination to be carried out between the flanking region and their corresponding DNA regions upstream or downstream of the preselected site. The DNA region flanking the preselected site with homology to the flanking DNA region of the repair nucleic acid molecule is also referred to as the homologous region in the genomic DNA.

[0077] In order to have enough recombinant homology, the flanking DNA region length of the repair nucleic acid molecule can change, and the length should be at least about 10nt, about 15nt or about 20nt. However, the flanking region can be as long as possible (for example, up to about 100-150kb, as complete bacterial artificial chromosome (BAC)). Preferably, the flanking region is about 50nt to about 2000nt, for example about 100nt, 200nt, 500nt or 1000nt. In addition, the target DNA flanking region does not need to be identical with the homology region (DNA region of the preselected site flank), and can have about 80% to about 100% sequence identity, preferably about 95% to about 100% sequence identity with the DNA region of the preselected site flank. The flanking region is longer, and the requirement to homology is less strict. In addition, in order to realize the exchange of the target DNA sequence at the preselected site without changing the DNA sequence of the adjacent DNA sequence, the flanking DNA sequence should preferably be identical with the upstream and downstream DNA regions of the preselected site flank.

[0078] As used herein, "upstream" refers to a position on a nucleic acid molecule that is closer to the 5' end of the nucleic acid molecule. Similarly, the term "downstream" refers to a position on a nucleic acid molecule that is closer to the 3' end of the nucleic acid molecule. For the avoidance of doubt, nucleic acid molecules and their sequences are usually expressed in their 5' to 3' direction (from left to right).

[0079] In order to modify the target sequence at the preselected site, the flanking region must be selected so that the 3' end of the upstream flanking region and / or the 5' end of the downstream flanking region are aligned with the ends of the predetermined site. Thus, the 3' end of the upstream flanking region determines the 5' end of the predetermined site, while the 5' end of the downstream flanking region determines the 3' end of the predetermined site.

[0080] As used herein, the preselected site is located outside or away from the cleavage (and / or recognition) site, meaning that the site (preselected site) for genome modification is expected to not include the cleavage site and / or recognition site of the SSBI or DSBI enzyme, i.e., the preselected site does not overlap with the cleavage (and / or recognition) site. Therefore, outside / away from in this regard refers to upstream or downstream of the cleavage (and / or recognition) site.

[0081] Steps (c) and (d) of the above method for producing genetically modified plants are carried out as described above in the context of producing transgenic plants. Thus, modified plant cells that have been gene-edited and may have a modified genome are regenerated into complete (fertile) plants.

[0082] Another aspect of the present invention still relates to the production of haploid and double haploid plant embryos and plants. It has been found that the beneficial effects of hyperphyllin and its derivatives on callus formation can also be used to produce haploid and double haploid plant embryos. Therefore, the present invention provides a method for producing haploid plant embryos, the method comprising the following steps:

[0083] (a) inducing callus formation from immature male gametophytes or microspores according to the above method to produce callus,

[0084] (b) cultivating the callus obtained in step (a) according to the above method to produce plantlets, and

[0085] (c) Optionally, chromosome doubling is performed.

[0086] The haploid or double haploid plant embryos obtained in this way can then be regenerated into mature plants. Therefore, the present invention provides a method for producing haploid or double haploid plants, the method comprising the following steps:

[0087] (a) inducing callus formation from immature male gametophytes or microspores according to the above method to produce callus,

[0088] (b) cultivating the callus obtained from step (a) according to the above method to produce plantlets,

[0089] (c) optionally performing chromosome doubling, and

[0090] (d) Regenerating haploid or doubled haploid plants.

[0091] A haploid is a plant (sporophyte) that contains the same number of chromosomes as its gametes. Spontaneous haploid individuals have been found in several plant species. However, spontaneous evidence is a rare event, resulting in limited applications. Therefore, artificial haploid induction is a prerequisite for potential applications in breeding. Induction protocols vary widely, not only between species, but also between genotypes within the same species.

[0092] In the method of the present invention, immature male gametophytes or microspores are used as starting materials for producing haploids and double haploids. In step (a), under conditions that promote callus growth as described above, callus formation is induced. The method relies on the ability of immature male gametophytes and microspores to convert their developmental pathways from gametophytes (causing pollen grains to mature) to sporophytes, resulting in the formation of callus and embryos after cell division at the haploid level. This process can be induced by several factors. The most widely used triggering factors are temperature pretreatment, sucrose and nitrogen starvation, and osmotic stress. In addition to stress treatment, culture medium components also have a significant impact. Depending on the plant involved, the technician can select from various known methods suitable for inducing callus formation from immature male gametophytes or microspores.

[0093] In step (b), callus tissue is cultured under the conditions described in detail above to induce shoot formation.

[0094] Because there is not a set of homologous chromosomes in haploid plants, meiosis cannot occur, so there is no seed formation. Therefore, the duplication of chromosome complement can be completed in the step (c) of the above method, for the production of haploid and double haploid plant embryos and plants. Various technologies have been applied for decades, and are well known to those skilled in the art. The most commonly used application is anti-microtubule drugs, such as the treatment of colchicine (originally extracted from colchicine), which inhibits microtubule polymerization by binding to tubulin. Although colchicine is highly toxic when used in millimolar concentrations, and is known to be more efficient in animal bodies than in plant tissues, it remains the most widely used multiplier. Other selections are oryzalin, amiprophosmethyl (APM), trifluralin and natrol, all of which are used as herbicides and are effective under micromolar concentrations.

[0095] Anti-microtubule drugs can be applied at various stages of the above methods, such as incorporation into microspore pretreatment medium. The advantage of treating plants at a later stage of development is that only haploid regenerants that have been tested are treated in vitro (e.g., at the seedling culture stage) or in vivo after acclimation. The concentration and duration of the treatment must always be correlated with two effects: the percentage of doubled plants and the percentage of survival.

[0096] The present invention is applicable to any plant species, whether monocot or dicot. Preferably, the plants that can be treated by the methods and uses of the present invention are selected from the group consisting of barley (Hordeum vulgare), bulbous barley (Hordeum bulbusom), bicolor sorghum (Sorghum bicolor), sugarcane (Saccharum officinarium), Zea spp., including corn (Zea spp.), millet (Setaria italica), small-grain rice (Oryza minuta), rice (Oryza sativa), Australian wild rice (Oryza australiensis), tall wild rice (Oryza alta), wheat (Triticum aestivum), durum wheat (Triticum durum), rye (Secale cereale), triticale (Triticale), apple (Malus domestica), purple short-handled grass (Brachypodium distachyon), seashore barley (Hordeum marinum), knotweed (Aegilops tauschii), hook-mouthed carrot (Daucus glochidiatus), including sugar beet (Beta vulgaris (Beta spp.), Daucus pusillus, Daucus muricatus, Daucus carota, Eucalyptus grandis, Nicotiana sylvestris, Nicotianatomentosiformis, Nicotiana tabacum, Nicotiana benthamiana, Solanum lycopersicum, Solanum tuberosum, Coffea canephora, Vitis vinifera, Erythrante guttata, Genlisea aurea, Cucumissativus, Marus notabilis, Arabidopsis arenosa, Arabidopsis lyrata, Arabidopsis thaliana, Crucihimalaya himalaica, Crucihimalaya wallichii), Cardamine nexuosa, Lepidiumvirginicum, Capsella bursa pastoris, Olmarabidopsis pumila, Arabishirsute, Brassica napus, Brassica oleracea, Brassicarapa, Raphanus sativus, Brassica juncacea, Brassica nigra, Eruca vesicaria subsp. sativaSativa), Citrus sinensis, Jatropha curcas, Populus trichocarpa, Medicagotruncatula, Cicer yamashitae, Cicer bijugum, Cicer rietinum, Cicer reticulatum, Cicer judaicum, Cajanuscajanifolius, Cajanus scarabaeoides, Phaseolus vulgaris, Glycine max, Gossypium sp., Astragalus sinicus, Lotus japonicas, Torenia fournieri, Allium cepa, Allium fistulosum, Allium sativum, Helianthus annuus), Jerusalem artichoke (Helianthustuberosus) and / or leek (Allium tuberosum). Particularly preferred are sugar beet, corn, wheat, barley, rye, sunflower, potato, bicolor sorghum, turnip, rapeseed, mustard, cabbage, soybean and / or cotton.

[0097] The subject of the present invention is also a plant obtained or obtainable by the above method. Therefore, one embodiment of the present invention is a transgenic plant obtained or obtainable by the above method of transforming plant cells and regenerating plants from the cells, and progeny or parts thereof, wherein the progeny or parts comprise at least one nucleotide sequence of interest as a transgene. Another embodiment of the present invention is a genetically modified plant obtained or obtainable by the above method of modifying the genome of plant cells and regenerating plants from the cells, and progeny or parts thereof, wherein the progeny or parts comprise the modification of the genome introduced by the method of the present invention. Another embodiment of the present invention is a haploid or double haploid plant obtained or obtainable by the above method of producing haploid plant embryos.

[0098] A further subject of the present invention is a plant cell or seed derived from the above transgenic plant or genetically modified plant. The plant cell derived from the above transgenic plant comprises at least one nucleotide sequence of interest as a transgene, while the plant cell derived from the above genetically modified plant comprises a modification in its genome.

[0099] Another embodiment of the present invention is a plant cell or seed derived from the above haploid or double haploid plant. The plant cell or seed comprises a haploid or double haploid set of chromosomes.

[0100] The present invention will be further described with reference to the following figures and examples. However, it should be understood that the present invention is not limited to such examples.

[0101] Unless otherwise indicated in the examples, all recombinant DNA techniques were performed according to standard protocols as described in Sambrook et al. (1989) Molecular Cloning: A Laboratory Manual, Second Edition, Cold Spring Harbor Laboratory Press, NY and Volumes 1 and 2 of Ausubel et al. (1994) Current Protocols in Molecular Biology, Current Protocols, USA. Standard materials and methods for plant molecular studies are described in Plant Molecular Biology Labfax (1993) by RDD Ray, jointly published by BIOS Scientific Publishing Ltd. (UK) and Blackwell Scientific Publishers (UK). Other references for standard molecular biology techniques include Sambrook and Russell (2001) Molecular Cloning: A Laboratory Manual, Third Edition, Cold Spring Harbor Laboratory Press, NY, Volumes I and II of Brown (1998) Molecular Biology LabFax, Second Edition, Academic Press (UK). Standard materials and methods for polymerase chain reaction can be found in Dieffenbach and Dveksler (1995) PCR Primer: A Laboratory Manual, Cold Spring Harbor Laboratory Press, and McPherson et al. (2000) PCR-Basics: From Background to Bench, First Edition, Springer Verlag, Germany.

[0102] All patents, patent applications, and publications or public disclosures (including publications on the Internet) mentioned or cited herein are incorporated by reference. BRIEF DESCRIPTION OF THE DRAWINGS

[0103] Figure 1 : Shown are the chemical formulas of hyperphyllin (HP; N-[4-amino-2-chlorophenyl]-2,4-dichlorobenzamide; CAS#: 42480-64-8) and its three different derivatives A1, A2 and A3.

[0104] Figure 2 : Diagrams showing the binary vectors pZFN-nptII-70s::AtGRF5 (A) and pZFN-nptII-70s::tDT (B).

[0105] Figure 3 : Demonstration of the promotion of callus induction in the recalcitrant genotype A treated with HP at concentrations of 30 μM and 50 μM. Upper panel: 30 μM HP significantly promoted callus induction in the recalcitrant genotype A; Lower panel: 50 μM HP had a similar effect, but no further increase in efficiency. Arrows indicate callus formation. DMSO without HP served as a control.

[0106] Figure 4 : Shows the callus induction efficiency without (-HP) and with HP (+HP), and demonstrates the enhancing effect of HP on two replicates of the recalcitrant genotype A and the additional genotype B.

[0107] Figure 5 : Shows that HP (30 μM)-induced callus (+HP) produced a greater amount of callus compared to the control without HP (-HP).

[0108] Figure 6 : Shows a comparison of plantlet regeneration from callus without (-HP) and with HP (+HP) induction. HP-mediated induction resulted in more plants regenerated from callus.

[0109] Figure 7 : shows fluorescence imaging of HP-induced callus of suitable genotype C and recalcitrant genotype A 7 days after Agrobacterium infection. Both genotypes have been transformed with the 70s::tDT construct (see also Figure 2 B) Bright spots and sectors indicate successful Agrobacterium-mediated transformation.

[0110] Figure 8 : It is shown that HP-induced and genetically modified calli of some recalcitrant genotypes (such as genotype A) can only be regenerated into completed plants by co-transformation with a regeneration-enhancing gene (such as AtGRF5).

[0111] Fig. 9: Shows that the HP derivative A2 (50 μM) promotes callus induction in recalcitrant genotypes (right column). Left column: Control without HP treatment. Example

[0112] 1. Description of binary plasmids

[0113] The binary vector was produced by following standard cloning procedures ( Figure 2 )pZFN-nptII-70s::AtGRF5 and pZFN-nptII-70s::tDT (both structures are binary). Figure 2 As shown, within the T-DNA of this vector, the cDNA encoding ArGRF5 (DNA: SEQ ID NO: 1; amino acid: SEQ ID NO: 2) and tDTomato (tDT) as a fluorescent marker are cloned between the double CaMV 35S promoter and the terminator of the nopaline synthase (NOS) gene. The T-DNA also contains the neomycin phosphotransferase II (nptII) gene, which confers resistance to a series of aminoglycoside antibiotics (such as kanamycin or paromomycin) and is used to select transgenic plant cells and tissues. The NOS promoter and the pAG7 terminator are located on the flanks of the nptII gene. The backbone of the binary vector contains colE1 and pVS1 origins for Escherichia coli plasmid replication and Agrobacterium tumefaciens plasmid replication, respectively; and the aadA gene that confers streptomycin / spectinomycin resistance for bacterial selection.

[0114] Both plasmids were transformed into the AGL-1 Agrobacterium strain by standard procedures.

[0115] 2. Beet callus induction

[0116] 1. Micropropagated plantlets of various proprietary genotypes were used as starting material: Genotypes A and B were difficult to callus induction and plant regeneration. For example, genotype A did not show adequate callus induction and the callus quality was very poor. Therefore, such callus could never be transformed. Genotype C was less recalcitrant. Plantlets were propagated in MS salts + 30 g / L sucrose and 0.25 mg / L benzyl adenine (BAP).

[0117] 2. To induce brittle callus, leaf explants were isolated from micropropagated seedlings and incubated in callus induction medium (CIM) containing MS salts including 15 g / L sucrose and 2 mg / L BAP at 28°C for 7 to 8 weeks. 2 mL / L DMSO was added to the medium as a control or 30 μM HP dissolved in 2 mL / L DMSO or 50 μM HP dissolved in 2 mL / L DMSO. HP is hyperphyllin, a small molecule with the chemical formula N-[4-amino-2-chlorophenyl]-2,4-dichlorobenzamide (CAS#: 42480-64-8).

[0118] After the incubation period, callus induction and formation were analyzed. Figure 3 The results showed that in the recalcitrant genotype A, HP at concentrations of 30 μM and 50 μM promoted callus formation. There was no significant difference in the induction efficiency between these two concentrations. Quantification of callus induction efficiency with and without HP demonstrated the enhancing effect of HP on different recalcitrant genotypes (A and B), although genotype A ( Figure 4 A) has a higher efficiency than genotype B ( Figure 4 B). After transferring the induced callus on a single plate, it was observed that application of 30 μM HP could induce a greater amount of callus from leaves compared to the control without HP ( Figure 5 ).

[0119] 3. Beet seedling induction and proliferation

[0120] 3. Harvest the friable calli from step 2 from the inducer and transfer to shoot induction medium containing MS salts, 30 g / l sucrose, 1 mg / l GA3 and 1 mg / l thidiazuron (TDZ). The calli were incubated at 24°C with a light / dark cycle (16h / 8h) for 1 to 2 weeks.

[0121] 4. Mount and culture the regenerated shoots in the medium of step 1. Plants were grown at 24°C with a light / dark cycle (16h / 8h).

[0122] Figure 6 : Shows a comparison of plantlets regenerated from callus with and without HP induction. HP-induced callus can regenerate more plants. Plants induced with HP all showed normal phenotypes.

[0123] 4. Agrobacterium-mediated transformation of sugar beet callus

[0124] a. Sugar beet callus was induced as described in steps 1 and 2.

[0125] b. The brittle callus was fixed in a medium containing MS salts, 30 g / l sucrose, 1 mg / l GA3 and 1 mg / l thidiazuron (TDZ) and stored at 24°C in the dark for 1 week.

[0126] c. Grow Agrobacterium AGL-1 carrying the vectors pZFN-nptII-70s::AtGRF5 and pZFN-nptII-70s::tDT at 28°C for 24 h in culture medium (5 g / l tryptone + 2.5 g / l yeast extract + 1 g / l NaCl + 5 g / l mannitol + 0.1 g / l MgSO4×7H2O + 0.25 g / l KH2PO4 + 1 g / l glutamate, pH 7.0) supplemented with appropriate antibiotics.

[0127] d. At an OD600 of 0.8, callus was inoculated with an Agrobacterium suspension (medium: 440 mg / l CaCl2×2H2O+170 mg / l KH2PO4+1.9 g / l KNO3+180.7 mg / l MgSO4+1.65 g / l NH4NO3+2 mg / l BAP+40 μg l acetosyringone+20 g / l sucrose+2 g / l glucose, pH 6.0). Callus and Agrobacterium were incubated in a medium containing 440 mg / l CaCl2×2H2O, 170 mg / l KH2PO4, 1.9 g / l KNO3, 180.7 mg / l MgSO4, 1.65 g / l NH4NO3, 2 mg / l BAP, 40 μg / l acetosyringone, 20 g / l sucrose and 2 g / l glucose at 21°C in the dark for 3 days.

[0128] e. The callus was subcultured into a medium containing MS salts, 30 g / l sucrose, 1 mg / l GA3, 1 mg / l TDZ and 500 mg / l Timentin and incubated at 24°C in the dark for 1 week.

[0129] f. To select transgenic calli, samples were transferred to medium containing MS salts, 30 g / l sucrose, 1 mg / l GA3, 1 mg / l TDZ, 500 mg / l timentin and 100 mg / l paromomycin and incubated at 24°C under a light / dark cycle (16 h / 8 h) for 3 weeks.

[0130] g. Select transgenic callus and subculture several times under the same medium and conditions.

[0131] h. Regenerated shoots were isolated and propagated in medium containing MS salts, 30 g / l sucrose, 0.25 mg / l benzyl adenine (BAP) and 100 mg / l kanamycin.

[0132] i. Leaf explants were isolated from green growing shoots for DNA extraction and PCR analysis to confirm putative transgenic lines.

[0133] j. Selected shoots were rooted in medium (MS salts + 30 g / l sucrose + 6.25 mg / l NAA) and transferred to the greenhouse for seed production.

[0134] Figure 7 It was shown that HP-induced callus from recalcitrant genotypes can be infected by Agrobacterium. However, regeneration of transgenic plants from callus of recalcitrant genotypes is not always possible. Transgenic plants can usually only be obtained from HP-induced callus by additionally expressing regeneration-enhancing genes such as AtGRF5 (see PCT / EP2018 / 086902)( Figure 8 ).

[0135] In addition, different concentrations of HP (10, 30, 50, 100, 500 μM and 1 mM) were tested according to the above process. Only 30 and 50 μM showed a strong callus induction effect. However, 10 and 100 μM caused at least a moderate effect, while higher concentrations showed no effect (Table 1). In addition, HP derivatives A1 and A2 were tested at concentrations of 30 and 50 μM. Derivative A2 produced a strong callus induction effect at 30 μM ( Fig. 9 ), and produced only a weak effect at 50 μM. Derivative A1 was only effective at a concentration of 30 μM (Table 1).

[0136] Table 1: Tests of different HP derivatives at different concentrations (-: no callus induction effect; +: moderate callus induction effect; ++: strong callus induction effect

[0137] Chemical compounds Concentration (dissolved in 2ml / L DMSO) Callus induction effect HP 10μM + HP 30μM ++ HP 50μM ++ HP 100μM + HP 500μM - HP 1mM - HP derivative A1 30μM + HP derivative A1 50μM - HP derivative A2 30μM ++ HP derivative A2 50μM +

Claims

1. A method for inducing callus formation from plant cells, comprising incubating the plant cells in the presence of hyperphyllin or a derivative thereof, wherein the derivative is selected from The concentration of hyperphyllin is 10-100 μM, the concentration of A1 is 30 μM, and the concentration of A2 is 30-50 μM.

2. The method of claim 1, wherein the plant cell is incubated in a culture medium comprising hyperphyllin or a derivative thereof and / or wherein hyperphyllin or a derivative thereof is introduced into the plant cell.

3. A method for producing plant seedlings, comprising: (i) inducing callus formation according to the method of claim 1 or 2 to produce callus, and (ii) culturing the callus under conditions suitable for inducing shoot formation.

4. A method for producing transgenic plants, The following steps are involved: (a) inducing callus formation according to the method of claim 1 or 2 to produce callus, (b) introducing at least one nucleotide sequence of interest or at least one polypeptide of interest into the plant cells to be used in step (a) and / or into the cells of the callus obtained in step (a), (c) culturing the callus obtained from steps (a) and (b) according to the method of claim 3 to produce plantlets, and (d) Regeneration of transgenic plants.

5. A method for producing genetically modified plants, The following steps are involved: (a) inducing callus formation according to the method of claim 1 or 2 to produce callus, and (b) modifying the genome of the plant cells to be used in step (a) and / or the genome of the cells of the callus tissue obtained in step (a) by introducing a single-strand DNA break (SSB)-inducing enzyme or a double-strand DNA break (DSB)-inducing enzyme into the cells, and / or introducing a base editor fused to a catalytically impaired SSB or DSB-inducing enzyme or fused to an SSB-inducing enzyme into the cells, wherein the genomic modification is selected from i. substitution of at least one nucleotide; ii. a deletion of at least one nucleotide; iii. insertion of at least one nucleotide; or iv. any combination of i.-iii., (c) culturing the callus obtained from steps (a) and (b) to produce plantlets according to the method of claim 3, and (d) Regenerating the genetically modified plant.

6. The method of claim 5, wherein in step (b) a repair nucleic acid molecule is further introduced into the cell.

7. The method of claim 5 or 6, wherein the SSB-inducing enzyme or DSB-inducing enzyme recognizes a predetermined site in the genome of the cell, and / or the catalytically impaired SSB- or DSB-inducing enzyme or the SSB-inducing enzyme recognizes a predetermined site in the genome of the cell.

8. A method for producing haploid or doubled haploid plants, The following steps are involved: (a) inducing callus formation from immature male gametophytes or microspores to produce callus according to the method of claim 1 or 2, (b) culturing the callus obtained from step (a) according to the method of claim 3 to produce plantlets, and (c) Regenerating haploid or doubled haploid plants.

9. The method of claim 8, wherein chromosome doubling is performed between step (b) and step (c).

10. Use of hyperphyllin or a derivative thereof in a method for inducing callus formation from plant cells or in a method for indirect regeneration of plants, comprising incubating plant cells in the presence of hyperphyllin or a derivative thereof, inducing callus formation, wherein the derivative is selected from The concentration of hyperphyllin is 10-100 μM, the concentration of A1 is 30 μM, and the concentration of A2 is 30-50 μM.

11. Use of hyperphyllin or a derivative thereof in a method for producing transgenic plant cells, plants or seeds, in a method for producing genetically modified plant cells, plants or seeds, or in a method for producing haploid or doubled haploid plant cells, plants or seeds, comprising incubating plant cells in the presence of hyperphyllin or a derivative thereof to induce callus formation, wherein the derivative is selected from The concentration of hyperphyllin is 10-100 μM, the concentration of A1 is 30 μM, and the concentration of A2 is 30-50 μM.